Epidural Stimulation for Spinal Cord Injury
(TSEPI Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how epidural stimulation can help individuals with severe spinal cord injuries regain functions such as voluntary movement, standing, and autonomic nervous system improvement, which affects heart rate and blood pressure. Participants are divided into groups to test different aspects of epidural stimulation, including cardiovascular stability and voluntary movement enhancement. Individuals who have had a spinal cord injury for at least two years and experience challenges like difficulty moving their legs, standing, or cardiovascular issues such as low blood pressure may be suitable candidates for this study. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research and potentially improve quality of life.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you have an implanted pump or use nicotine, you may not be eligible to participate.
What prior data suggests that epidural stimulation is safe for spinal cord injury recovery?
Research has shown that epidural electrical stimulation (EES) is generally safe for people with spinal cord injuries. Studies have found that using EES with physical therapy can help restore movement and sensation. These studies have not shown strong evidence of serious side effects, suggesting EES is safe.
Early studies have found stand training to be safe for people with spinal cord injuries. Participants in these studies did not experience major side effects.
In summary, current research suggests that both epidural stimulation and stand training are safe for people with spinal cord injuries. These treatments are generally well-tolerated and show promise in improving movement and balance.12345Why are researchers excited about this trial?
Researchers are excited about epidural stimulation for spinal cord injury because it offers a new approach to improving cardiovascular stability and voluntary movement in affected individuals. Unlike traditional treatments that primarily focus on physical therapy and medications to manage symptoms, epidural stimulation directly targets the spinal cord to enhance nerve activity. This method has the potential to improve cardiovascular function and enable voluntary movements, which could significantly enhance quality of life. Additionally, combining this stimulation with stand training aims to further support physical function and stability. Overall, this innovative approach could lead to more effective and comprehensive management of spinal cord injury symptoms.
What evidence suggests that this trial's treatments could be effective for spinal cord injury?
Research has shown that epidural stimulation, one of the treatments in this trial, can benefit people with severe spinal cord injuries in several ways. Studies have found that this treatment can restore some voluntary movement, allowing individuals to regain control over their legs and upper body. It can also improve heart and blood circulation, stabilizing blood pressure and enhancing overall heart function. These findings suggest that epidural stimulation could enhance the quality of life for those with severe spinal cord injuries. Participants in this trial will be assigned to different arms to assess the effects of epidural stimulation on cardiovascular stability, voluntary movement, or a combination with stand training.36789
Who Is on the Research Team?
Susan J Harkema, PhD
Principal Investigator
University of Louisville
Are You a Good Fit for This Trial?
This trial is for adults over 18 with severe spinal cord injury, unable to stand or move legs voluntarily, and experiencing issues like low blood pressure and respiratory dysfunction. They should be at least two years post-injury with stable health but can't join if they use nicotine, have certain implants, untreated conditions, or are pregnant.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive lumbosacral spinal cord epidural stimulation (scES) for cardiovascular function, voluntary movement, or standing with and/or without weight-bearing standing.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of cardiovascular, respiratory, bladder, bowel, and sexual function.
Open-label extension (optional)
Participants may opt into continuation of treatment long-term to further assess quality of life and healthcare costs.
What Are the Treatments Tested in This Trial?
Interventions
- Epidural Stimulation
- Stand Training
Epidural Stimulation is already approved in United States, Canada, European Union for the following indications:
- Spinal cord injury rehabilitation
- Motor function recovery
- Autonomic function recovery
- Spinal cord injury rehabilitation
- Motor function recovery
- Autonomic function recovery
- Spinal cord injury rehabilitation
- Motor function recovery
- Autonomic function recovery
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Louisville
Lead Sponsor
Christopher Reeve Paralysis Foundation
Collaborator